We are live on ! Find out more
MCM

Monarch Capital Management Portfolio holdings

AUM $436M
1-Year Est. Return 26.61%
This Fund
S&P 500
This Quarter Est. Return
+3.56%
1 Year Est. Return
+26.61%
3 Year Est. Return
+65.03%
5 Year Est. Return
+87.16%
10 Year Est. Return
+267.35%
AUM
$268M
AUM Growth
+$4.05M
Cap. Flow
-$4.11M
Cap. Flow %
-1.53%
Top 10 Hldgs %
31.47%
Holding
96
New
2
Increased
12
Reduced
52
Closed
4

Top Buys

Rank Stock Value
1
FRME icon
First Merchants
FRME
+$411K
2
GE icon
GE Aerospace
GE
+$347K
3
GILD icon
Gilead Sciences
GILD
+$304K
4
FLS icon
Flowserve
FLS
+$278K
5
OKE icon
Oneok
OKE
+$271K

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$571K
2
MCD icon
McDonald's
MCD
+$401K
3
JNJ icon
Johnson & Johnson
JNJ
+$305K
4
OKS
Oneok Partners LP
OKS
+$260K
5
MMM icon
3M
MMM
+$238K

Sector Composition

Rank Sector Weight
1 Healthcare 24.6%
2 Industrials 14.44%
3 Technology 13.5%
4 Consumer Staples 13.06%
5 Financials 12.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ELV icon
76
Elevance Health
ELV
$81.5B
$372K 0.14%
1,960
– –
ITW icon
77
Illinois Tool Works
ITW
$82.6B
$345K 0.13%
2,333
-100
-4% -$14.2K
MDLZ icon
78
Mondelez International
MDLZ
$79.5B
$325K 0.12%
7,999
– –
LNC icon
79
Lincoln National
LNC
$8.73B
$316K 0.12%
4,300
– –
CDK
80
DELISTED
CDK Global, Inc.
CDK
$288K 0.11%
4,567
-2,198
-32% -$138K
OKE icon
81
Oneok
OKE
$57.2B
$278K 0.1%
+5,022
New +$271K
BRK.A icon
82
Berkshire Hathaway Class A
BRK.A
$1.1T
$275K 0.1%
1
– –
NKE icon
83
Nike
NKE
$61.9B
$274K 0.1%
5,275
– –
NUE icon
84
Nucor
NUE
$58.6B
$269K 0.1%
4,794
-150
-3% -$8.48K
GWW icon
85
W.W. Grainger
GWW
$65.3B
$266K 0.1%
1,482
-500
-25% -$84.3K
STZ icon
86
Constellation Brands
STZ
$22.2B
$244K 0.09%
1,225
– –
DUK icon
87
Duke Energy
DUK
$97.8B
$235K 0.09%
2,804
– –
KHC icon
88
Kraft Heinz
KHC
$30.7B
$234K 0.09%
3,012
– –
HSBC.PRA
89
DELISTED
HSBC Holdings PLC, Inc. ADS(1/40 shr. 6.2% Non-Cum. Dlr. Pref. Shrs., Ser.A)
HSBC.PRA
$222K 0.08%
8,400
– –
QEP
90
DELISTED
QEP RESOURCES, INC.
QEP
$166K 0.06%
19,325
– –
WLL
91
DELISTED
Whiting Petroleum Corporation
WLL
$78K 0.03%
48
– –
SSY
92
DELISTED
SunLink Health Systems
SSY
$36K 0.01%
23,947
– –
ORCL icon
93
Oracle
ORCL
$374B
– –
-4,628
Closed -$232K
TEVA icon
94
Teva Pharmaceuticals
TEVA
$40.8B
– –
-17,200
Closed -$571K
TGNA
95
DELISTED
TEGNA Inc
TGNA
– –
-14,415
Closed -$208K
OKS
96
DELISTED
Oneok Partners LP
OKS
– –
-5,100
Closed -$260K
1 2 3
4

Similar funds

VDBMI
Van Den Berg Management I Austin, Texas $436M AUM 40.66% 1-Year Est. Return
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
VIM
VELA Investment Management New Albany, Ohio $436M AUM 15.16% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
SCP
Seafarer Capital Partners Larkspur, California $436M AUM 42.05% 1-Year Est. Return
SWG
Summit Wealth Group White River Junction, Vermont $436M AUM 13.96% 1-Year Est. Return
VBA
von Borstel & Associates The Dalles, Oregon $437M AUM 17.93% 1-Year Est. Return
BCM
Beck Capital Management Austin, Texas $437M AUM 59.35% 1-Year Est. Return

Monarch Capital Management's Q3 2017 Portfolio in Review

As of Q3 2017, Monarch Capital Management held 96 positions worth $268M, up 1.5% from $264M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Monarch Capital Management's Q3 2017 filing shows 2 new, 12 increased, 52 reduced and 4 closed positions. Its largest new stake was First Merchants: 10,331 shares worth $444K. The largest sale was Teva Pharmaceuticals, an estimated $571K.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 25% a quarter earlier, followed by Industrials and Technology.

  • Monarch Capital Management's largest Q3 2017 buy was First Merchants: 10,331 shares worth $444K.
  • Monarch Capital Management added most to GE Aerospace in Q3 2017, an estimated $347K increase.
  • Monarch Capital Management's biggest Q3 2017 reduction was McDonald's, cutting an estimated $401K.
  • Monarch Capital Management fully exited Teva Pharmaceuticals in Q3 2017, selling an estimated $571K.
  • Monarch Capital Management's ten largest holdings make up 31% of its $268M portfolio in Q3 2017.
  • Monarch Capital Management opened 2 new positions and closed 4 in Q3 2017.
  • Monarch Capital Management's portfolio value rose 1.5% quarter-over-quarter to $268M.

Based on Monarch Capital Management's 13F filing for Q3 2017, filed 18 Oct 2017.